Indicator RSI is indicating buying momentum and stock might rise. Recent prices of GLMD Galmed Pharmaceuticals Ltd. are as follows: Daily volume is divided by

2021-04-03 · Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.67 and traded as low as $3.33. Galmed Pharmaceuticals shares last traded at $3.44, with a volume of 181,852 shares changing hands. A number of research firms have recently issued […]

GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 12, 2021 1:49 PM GLMD 3.26 0.11 (3.27%). 3,048 View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices.

Galmed pharmaceuticals stock

The average price target represents a 411.87% increase from the last price of $3.37. GALMED PHARMACEUTICALS LTD. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share GALMED PHARMACEUTICALS LTD. | Nasdaq: GLMD | Nasdaq About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 09, Friday current price of GLMD stock is 3.370$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Galmed Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. Historical daily share price chart and data for Galmed Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Galmed Pharmaceuticals as of March 12, 2021 is 3.50..

Madrigal Pharmaceuticals; Andra i horisonten. Anonim Squibb, tillsammans med mindre spelare som Galectin Therapeutics och Galmed Pharmaceuticals .

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) stock closed at 3.33 per share at the end of the most recent trading day (a -2.35 % change compared to the prior day closing price) with a volume of 169.68K shares and market capitalization of 83.53M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 21 … 2021-02-12 Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.

View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Investors Center News Events & Presentations SEC Filings 2018-06-12 (NASDAQ: GLMD) Galmed Pharmaceuticals Ltd currently has 21,018,919 outstanding shares. With Galmed Pharmaceuticals Ltd stock trading at $3.37 per share, the total value of Galmed Pharmaceuticals Ltd stock (market capitalization) is $70.83M. Search for Galmed Pharmaceuticals. Find the stock by name or ticker symbol: GLMD. Research its history to confirm it's a solid investment against your financial goals. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Galmed Pharmaceuticals … Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Search for Galmed Pharmaceuticals. Find the stock by name or ticker symbol: GLMD. Research its history to confirm it's a solid investment against your financial goals. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Galmed Pharmaceuticals … Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-03-18 2020-06-06 Based on 4 analysts offering 12 month price targets for Galmed Pharmaceuticals in the last 3 months.
Byta binda på natten

Since then, GLMD stock has decreased by 20.0% and is now trading at $3.37. 2021-03-15 · View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2 dagar sedan · Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. 2 dagar sedan · GLMD Galmed Pharmaceuticals Ltd. — Stock Price and Discussion | Stocktwits.

Nash covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, Akero Therapeutics, and Theratechnologies. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Galmed Pharmaceuticals with a $17.25 average price target, a …

The average price target represents a 411.87% increase from the last price of $3.37. 2018-06-12 · Here's Why Galmed Pharmaceuticals Ltd. Was Up 19% Today and 33% for the Week 3 NASH Stocks That Could Soar in the Second Half of 2018 Are These Red-Hot NASH Stocks Still a Buy? 7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 449.78%. The high price target for GLMD is $33.00 and the low price target for GLMD is $8.00.

Tre student

Madrigal Pharmaceuticals; Andra i horisonten. Anonim Squibb, tillsammans med mindre spelare som Galectin Therapeutics och Galmed Pharmaceuticals .

Galmed Pharmaceuticals Ltd. in its current legal structure was incorporated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile. 2021-01-19 TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced the pricing of the underwritten public offering of 2,197,803 of its ordinary shares for gross proceeds of approximately $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Galmed.